InsiderInsights.com Daily Round Up 9/22/16: Immune Design, First Trust Dividend & Income Fund, Hyster Yale Materials Handling

Dollar value is only one metric to assess the significance of an insider transaction, but when high dollar value intersects with significance it spotlights a stock investors should take the time to consider. InsiderInsights Daily Round Up articles are intended as initial research tools, so investors can separate real insider investment intelligence from time-wasting noise.
Click the Company Name links in the tables below to analyze a company's or insider's full insider history.
On Today's Tables:
Insider trades were rated Significant at:
Immune Design (Nasdaq: IMDZ); Hyster Yale Materials Handling (NYSE: HY), and; First Trust Dividend & Income Fund (NYSE: FAV). Insider trades were rated Nearly Significant at:
Performance Sports (NYSE: PSG); Spark Networks (NYSEMKT:LOV), and; Hd Supply (Nasdaq: HDS). Insider trades were considered Insignificant at:
Gdl Fund (GDLPRB); Capricor Therapeutics (Nasdaq: CAPR); Deutsche High Income Trust (NYSE: KHI); Vonage (NYSE: VG); Rex American (NYSE: REX); Finisar (Nasdaq: FNSR); Fiserv (Nasdaq: FISV); Facebook (Nasdaq: FB); Evolent Health (NYSE: EVH), and; Coherent (Nasdaq: COHR). There is a Conflicted Insider Signal (both purchases & sales) at:
Neogenomics (Nasdaq: NEO), and; Hewlett Packard Enterprise (NYSE: HPE). There is an IPO or Known Corporate Action at:
Tobira Therapeutics (Nasdaq: TBRA). It's difficult to argue significance for most transactions made during IPOs, or when insiders make... Read more